Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing

Launched by NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST · Jan 21, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a type of therapy called Acceptance and Commitment Therapy (ACT), which is delivered online to help improve the well-being of young people who have survived brain tumors. Many childhood brain tumor survivors face challenges in their physical and mental health, so this study aims to see if ACT can help them feel better and improve their quality of life. The trial will involve participants aged 11 to 24 years who have finished their cancer treatment and are stable for at least six months.

If eligible, participants will be randomly assigned to either receive 12 weeks of ACT therapy right away or to wait 12 weeks before starting. Throughout the study, researchers will check in with participants to assess how well the therapy works and its lasting effects over time. Participants will also share their experiences through evaluations and interviews, helping researchers understand if this approach is helpful and acceptable. Overall, this study hopes to find effective ways to support young brain tumor survivors in their recovery journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 11-to-24 years at the time of randomisation
• • Received treatment for a brain tumour at a participating Principle Treatment Centre
• • Active brain tumour treatment is complete and their condition stable for at least six-months
• • Have sufficient cognitive ability to engage with ACT sessions as judged by the clinician at baseline assessment
• • competent to provide informed consent (participants aged 16 or over) or assent (participants aged 11-15)
• • Parent/carer competent to provide informed consent (for participants aged 11-15)
• Exclusion Criteria:
• • Received a structured behavioural intervention within six-months prior to study recruitment
• • Previous or current alcohol/substance dependence, psychosis, suicidality, or eating disorder
• • Moderate or severe intellectual disability, confirmed through researcher judgement at screening through questions relating to school type and previous diagnoses
• • Immediate risk to self or others
• • The patient or their parent/carer is not able to speak, read or write English